Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen

Cell Proliferation

Volumn 32, Issue 5, 1999, Pages 289-302

  Budtz, P E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSTASIS; GROWTH CURVE; HUMAN; HUMAN CELL; LABELING INDEX;

EID: 0033429147     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1999.3250289.x     Document Type: Article

References (48)

1. ATEN JA, BAKKER PJM, STAP J, BOSCHMAN GA, VEENHOF CHN. (1992) DNA double-labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication. Histochem. J. 24, 251.
2. BARDON S, VIGNON F, DEROCQ D, ROCHEFORT H. (1984) The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Mol. Cell. Endocrinol. 35, 89.
3. BERTHOIS Y, KATZENELLENBOGEN JA, KATZENELLENBOGEN BS. (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 83, 2496.
4. BRIAND P, LYKKESFELDT AE. (1984) Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. Cancer Res. 44, 1114.
5. BRUNO S, DI VINCI A, GEIDO E, GIARETTI W. (1988) Cell cycle synchronization induced by tamoxifen and 17β-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine. Breast Cancer Res. Treat. 11, 221.
6. BRÜNNER N, BRONZERT D, VINDELØV LL, RYGAARD K, SPANG-THOMSEN M, LIPMANN ME. (1989) Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res. 49, 1515.
7. BURSCH W, ELLINGER A, KIENZL H et al. (1996) Active cell death induced by the antiestrogens tamoxifen and ICI 164, 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17, 1595.
8. CAI J, LEE CW. (1996) Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells. Biochem. J. 320, 991.
9. CAVAILLES V, AUGEREAU P, GARCIA M, ROCHEFORT H. (1988) Estrogens and growth factors induce mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucl Acids Res. 16, 1903.
10. CHEN H, TRITTON TR, KENNY N, ABSHER M, CHIU JF. (1996) Tamoxifen induces TGF-β1 activity of human breast cancer cells in vitro. J. Cell. Biochem. 61, 9.
11. FRANKFURT OS, SUGARBAKER EV, ROBB JA, VILLA L. (1995) Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors. Cancer Lett 97, 149.
12. GULINO A, BARRERA G, VACCA A et al. (1986) Calmodulin antagonism and growth inhibiting activity of triphenylethylene anti-estrogens in MCF-7 human breaast cancer cells. Cancer Res. 46, 6274.
13. KASID A, DAVIDSON NE, GELMANN EP, LIPPMANN ME. (1986) Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells. J. Biol. Chem. 261, 5562.
14. KERR JFR, WYLLIE AH, CURRIE AR. (1973) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239.
15. KYPRIANOU N, ENGLISH HF, DAVIDSON NE, ISAACS JT. (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51, 162.
16. LAM H-YP. (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem. Biophvs. Res. Commun. 118, 27.
17. 1-antichymotrypsin-like 66 kDa protein from the human breast cancer cell line MCF-7. Biochim. Biophys. Acta 1121, 119.
18. LAURSEN I, BRIAND P, LYKKESFELDT AE. (1990) Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res. 10, 343.
19. LEUNG BS, POTTER AH. (1987) Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population. J. Cell. Biochem. 34, 213-225.
20. LIPPMAN M, BOLAN G, HUFF K. (1976) Interactions of antiestrogens with human breast cancer in long-term tissue culture. Cancer Treat. Report 60, 1421.
21. LYKKESFELDT AE. (1997) Growth regulation of human breast cancer cells by estrogens and antiestrogens. Thesis, University of Copenhagen (ISBN 87-90212-142).
22. LYKKESFELDT AE, BRIAND P. (1986) Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines. Br. J. Cancer 53, 29.
23. LYKKESFELDT AE, LARSEN JK, CHRISTENSEN IJ, BRIAND P. (1984) Effects of the antiestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br. J. Cancer 49, 717.
24. LYKKESFELDT AE, LARSEN JK, CHRISTENSEN IJ, BRIAND P. (1986a) Cell cycle analysis of estrogen-stimulated growth of the human breast cancer cell line MCF-7. Eur. J. Cancer Clin. Oncol. 22, 439.
25. LYKKESFELDT AE, LARSEN JK, CHRISTENSEN IJ. (1986b) Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7. Breast Cancer Res. Treat. 7 (Suppl.), 83.
26. LYKKESFELDT AE, LAURSEN I, BRIAND P. (1989) Regulation of the secretion of proteins synthesized by the human breast cancer cell line, MCF-7. Mol. Cell. Endocrinol. 62, 287.
27. LYKKESFELDT AE, LAURSEN I, BRIAND P. (1992) The role of estrogen regulated secreted proteins for growth regulation of human breast cancer cells. In: DOGLIOTTI L, SAPINO A, BUSSOLATI G, eds. Breast Cancer: Biological and Clinical Progress. Boston: Kluwer Academic Publishers, 81.
28. R-1. Cancer Res. 54, 1587.
29. MOURIDSEN H, PALSHOF T, PATTERSON J, BATTERSBY L. (1978) Tamoxifen in advanced breast cancer. Cancer Treat. Rev. 5, 131.
30. 1 phase. Cancer Res. 43, 3583.
31. OSBORNE CK, HOBSS K, CLARK GM. (1985) Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45, 584.
32. OSBORNE CK, CORONADO EB, ROBINSON JP. (1987) Human breast cancer in the athymic nude mouse: Cytostatic effects of long-term antiestrogen therapy. Eur. J. Cancer Clin. Oncol. 23, 1189.
33. OTTO AM, PADDENBERG R, SCHUBERT S, MANNHERZ HG. (1996) Cell cycle arrest, micronucleus formation, and cell death of MCF-7 breast cancer cells by amoxifen and cisplatin. J. Cancer Res. Clin. Oncol. 122, 603.
34. PERRY RR, KANG Y, GREAVES B. (1995) Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann. Surg. Oncol. 2, 238.
35. PIKE MC, SPICER DV, DAHMOUSH L, PRESS MF. (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15, 17.
36. REDDEL RR, SUTHERLAND RL. (1984) Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. Eur. J. Cancer Clin. Oncol. 20, 1419.
37. SAMTEN RJ, MANNI A, HARVEY H, REDMOND C. (1990) Endocrine treatment of breast cancer in women. Endocrine Rev. 11, 221-265.
38. 1 phase of the cell cycle. Eur. J. Cancer Clin. Oncol. 19, 615.
39. TAMIR S, KADNER SS, KATZ J, FINLAY TH. (1990) Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer cell sublines. Endocrinology 127, 1319.
40. TENNISWOOD M, TAILLEFER D, LAKINS J et al. (1994) Control of gene expression during apoptosis in hormone-dependent tissues. In: TOMEI LD, COPE FO, eds. Apoptosis II: Molecular Basis of Apoptosis in Disease. Cold Spring Habor, NY: Cold Spring Harbor Laboratory Press, 283.
41. VAN DER BURG B, VAN SELM-MILTENBURO AJP, LAAT SW, VAN ZOELEN EJJ. (1989) Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol. Cell. Endocrinol. 64, 223.
42. WANG TTY, PHANG JM. (1995) Effects of estrogen on apoptotic pathways in the human breast cancer cell line MCF-7. Cancer Res. 55, 2487.
43. WATTS CKW, SWEENEY KJE, WARLTERS A, MUSGROVE EA, SUTHERLAND RL. (1994) Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 31, 95.
44. WEICHSELBAUM RR, HELLMAN S, PIRO AJ, NOVE JJ, LITTLE JB. (1978) Proliferation kinetics of a human breast cancer line in vitro following treatment with 17β-estradiol and 1-β-D-arabino-furanosylcytosine. Cancer Res. 38, 2339.
45. WILSON JW, WAKELING AE, MORRIS ID, HICKMAN JA, DIVE C. (1995) MCF-7 human mammary adenocarcinoma cell death in response to hormone withdrawal and DNA damage. Int. J. Cancer 61, 502.
46. WRIGHT N, ALISON M. (1984) The Biology of Epithelial Cell Populations, Vol. 1. Oxford: Clarendon Press.
47. WÄRRI AM, HUOVINEN RL, LAINE AM, MARTIKAINEN PM, HÄKÖNEN PL. (1993) Apoptosis in torimifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. Natl. Cancer Inst. 85, 1412.
48. ZAKERI Z, BURSCH W, TENNISWOOD M, LOCKSHIN RA. (1995) Cell death: programmed, apoptosis, necrosis, or other? Cell Death Differ. 2, 87.